Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-10-09

Clinical Trial Update: An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorectal Cancer Who Have Been Previously Treated With 5-Fluorouracil/Leucovorin and Oxaliplatin [Phase 2]

View source ↗

Summary

An open-label Phase II study evaluating Indisulam in combination with Irinotecan in metastatic colorectal cancer patients who previously received 5-FU/leucovori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Indisulam (indisulam)
  • Irinotecan (Irinotecan)

Snippet

Sponsor: Eisai Limited | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED